Yousef Hannawi1, Lisa R Yanek2, Brian G Kral2, Lewis C Becker2, Dhananjay Vaidya2, Norman J Haughey3, Diane M Becker2, Paul A Nyquist4,5. 1. Division of Cerebrovascular Diseases and Neurocritical Care, Department of Neurology, The Ohio State University, Columbus, Ohio, USA. 2. GeneSTAR Research Program, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. 3. Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. 4. Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA, pnyquis1@jhmi.edu. 5. Neurosciences Critical Care Division, Departments of Neurology, Anesthesiology and Critical Care Medicine, Neurosurgery, Johns Hopkins University, University School of Medicine, Baltimore, Maryland, USA, pnyquis1@jhmi.edu.
Abstract
INTRODUCTION: We have demonstrated that asymptomatic cerebral small vessel disease (cSVD) measured by white matter hyperintensity volume is associated with reduced manipulative manual dexterity on the Grooved Peg Board Test (GPBT) in middle-aged healthy individuals with a family history of early coronary artery disease. In this current study, we aim to identify the association of subcortical white matter microstructural impairment measured by diffusion tensor imaging, manual dexterity measured by GPBT and circulating serums ceramide, another marker for white matter injury. We hypothesize that lower regional fractional anisotropy (rFA) is associated with worse performance on GPBT and elevated serum ceramides in the same study population. METHODS: rFA of 48 regions representing the subcortical white matters were analyzed in GeneSTAR participants in addition to serum ceramides and GPBT scores. Unadjusted univariable analyses with Bonferroni correction for multiple comparisons were completed using Spearman correlation for testing the associations between ceramides, rFA of subcortical white matter, and GPBT performance. Subsequently, sensitivity analyses were performed after excluding the participants that had any physical limitation that may influence their performance on GPBT. Finally, in the adjusted analysis using generalized estimating equation, linear regression models were performed for the areas that met significance threshold in the unadjusted analyses. RESULTS: 112 subjects (age [49 ± 11], 51% female, 39.3% African American) were included. Adjusted analyses for the significant correlations that met the Bonferroni correction threshold in the unadjusted univariable analyses identified significant negative associations between rFA of the right fornix (RF) and log-GPBT score (β = -0.497, p = 0.037). In addition, rFA of RF negatively correlated with log serum ceramide levels (C18: β = -0.03, p = 0.003, C20: β = -0.0002, p = 0.004) and rFA of left genu of corpus callosum negatively correlated with log C18 level (β = -0.0103, p = 0.027). CONCLUSIONS: These results demonstrate that subcortical microstructural white matter disruption is associated with elevated serum ceramides and reduced manual dexterity in a population with cSVD. These findings suggest that injury to white matter tracts undermines neural networks, with functional consequences in a middle-aged population with cardiovascular risk factors.
INTRODUCTION: We have demonstrated that asymptomatic cerebral small vessel disease (cSVD) measured by white matter hyperintensity volume is associated with reduced manipulative manual dexterity on the Grooved Peg Board Test (GPBT) in middle-aged healthy individuals with a family history of early coronary artery disease. In this current study, we aim to identify the association of subcortical white matter microstructural impairment measured by diffusion tensor imaging, manual dexterity measured by GPBT and circulating serums ceramide, another marker for white matter injury. We hypothesize that lower regional fractional anisotropy (rFA) is associated with worse performance on GPBT and elevated serum ceramides in the same study population. METHODS: rFA of 48 regions representing the subcortical white matters were analyzed in GeneSTAR participants in addition to serum ceramides and GPBT scores. Unadjusted univariable analyses with Bonferroni correction for multiple comparisons were completed using Spearman correlation for testing the associations between ceramides, rFA of subcortical white matter, and GPBT performance. Subsequently, sensitivity analyses were performed after excluding the participants that had any physical limitation that may influence their performance on GPBT. Finally, in the adjusted analysis using generalized estimating equation, linear regression models were performed for the areas that met significance threshold in the unadjusted analyses. RESULTS: 112 subjects (age [49 ± 11], 51% female, 39.3% African American) were included. Adjusted analyses for the significant correlations that met the Bonferroni correction threshold in the unadjusted univariable analyses identified significant negative associations between rFA of the right fornix (RF) and log-GPBT score (β = -0.497, p = 0.037). In addition, rFA of RF negatively correlated with log serum ceramide levels (C18: β = -0.03, p = 0.003, C20: β = -0.0002, p = 0.004) and rFA of left genu of corpus callosum negatively correlated with log C18 level (β = -0.0103, p = 0.027). CONCLUSIONS: These results demonstrate that subcortical microstructural white matter disruption is associated with elevated serum ceramides and reduced manual dexterity in a population with cSVD. These findings suggest that injury to white matter tracts undermines neural networks, with functional consequences in a middle-aged population with cardiovascular risk factors.
Authors: Paul A Nyquist; Lisa R Yanek; Murat Bilgel; Jennifer L Cuzzocreo; Lewis C Becker; Karinne Chevalier-Davis; David Yousem; Jerry Prince; Brian G Kral; Dhananjay Vaidya; Diane M Becker Journal: Neurology Date: 2015-04-10 Impact factor: 9.910
Authors: Serap Koybasi; Can E Senkal; Kamala Sundararaj; Stefka Spassieva; Jacek Bielawski; Walid Osta; Terry A Day; James C Jiang; S Michal Jazwinski; Yusuf A Hannun; Lina M Obeid; Besim Ogretmen Journal: J Biol Chem Date: 2004-08-17 Impact factor: 5.157
Authors: Kenichi Oishi; Andreia Faria; Hangyi Jiang; Xin Li; Kazi Akhter; Jiangyang Zhang; John T Hsu; Michael I Miller; Peter C M van Zijl; Marilyn Albert; Constantine G Lyketsos; Roger Woods; Arthur W Toga; G Bruce Pike; Pedro Rosa-Neto; Alan Evans; John Mazziotta; Susumu Mori Journal: Neuroimage Date: 2009-06 Impact factor: 6.556
Authors: Ilya M Nasrallah; Nicholas M Pajewski; Alexander P Auchus; Gordon Chelune; Alfred K Cheung; Maryjo L Cleveland; Laura H Coker; Michael G Crowe; William C Cushman; Jeffrey A Cutler; Christos Davatzikos; Lisa Desiderio; Jimit Doshi; Guray Erus; Larry J Fine; Sarah A Gaussoin; Darrin Harris; Karen C Johnson; Paul L Kimmel; Manjula Kurella Tamura; Lenore J Launer; Alan J Lerner; Cora E Lewis; Jennifer Martindale-Adams; Claudia S Moy; Linda O Nichols; Suzanne Oparil; Paula K Ogrocki; Mahboob Rahman; Stephen R Rapp; David M Reboussin; Michael V Rocco; Bonnie C Sachs; Kaycee M Sink; Carolyn H Still; Mark A Supiano; Joni K Snyder; Virginia G Wadley; Jennifer Walker; Daniel E Weiner; Paul K Whelton; Valerie M Wilson; Nancy Woolard; Jackson T Wright; Clinton B Wright; Jeff D Williamson; R Nick Bryan Journal: JAMA Date: 2019-08-13 Impact factor: 56.272
Authors: Jessica Alber; Suvarna Alladi; Hee-Joon Bae; David A Barton; Laurel A Beckett; Joanne M Bell; Sara E Berman; Geert Jan Biessels; Sandra E Black; Isabelle Bos; Gene L Bowman; Emanuele Brai; Adam M Brickman; Brandy L Callahan; Roderick A Corriveau; Silvia Fossati; Rebecca F Gottesman; Deborah R Gustafson; Vladimir Hachinski; Kathleen M Hayden; Alex M Helman; Timothy M Hughes; Jeremy D Isaacs; Angela L Jefferson; Sterling C Johnson; Alifiya Kapasi; Silke Kern; Jay C Kwon; Juraj Kukolja; Athene Lee; Samuel N Lockhart; Anne Murray; Katie E Osborn; Melinda C Power; Brittani R Price; Hanneke F M Rhodius-Meester; Jacqueline A Rondeau; Allyson C Rosen; Douglas L Rosene; Julie A Schneider; Henrieta Scholtzova; C Elizabeth Shaaban; Narlon C B S Silva; Heather M Snyder; Walter Swardfager; Aron M Troen; Susanne J van Veluw; Prashanthi Vemuri; Anders Wallin; Cheryl Wellington; Donna M Wilcock; Sharon Xiangwen Xie; Atticus H Hainsworth Journal: Alzheimers Dement (N Y) Date: 2019-04-09
Authors: Hanna Jokinen; Juha Koikkalainen; Hanna M Laakso; Susanna Melkas; Tuomas Nieminen; Antti Brander; Antti Korvenoja; Daniel Rueckert; Frederik Barkhof; Philip Scheltens; Reinhold Schmidt; Franz Fazekas; Sofia Madureira; Ana Verdelho; Anders Wallin; Lars-Olof Wahlund; Gunhild Waldemar; Hugues Chabriat; Michael Hennerici; John O'Brien; Domenico Inzitari; Jyrki Lötjönen; Leonardo Pantoni; Timo Erkinjuntti Journal: Stroke Date: 2019-11-08 Impact factor: 7.914
Authors: Yousef Hannawi; Eder Caceres; Mohamed G Ewees; Kimerly A Powell; Anna Bratasz; Jan M Schwab; Cameron L Rink; Jay L Zweier Journal: Front Neurol Date: 2021-11-30 Impact factor: 4.003
Authors: Yousef Hannawi; Dhananjay Vaidya; Lisa R Yanek; Michelle C Johansen; Brian G Kral; Lewis C Becker; Diane M Becker; Paul A Nyquist Journal: J Am Heart Assoc Date: 2022-05-27 Impact factor: 6.106